Patent Assignment
Reel/Frame 056932/0733
Assignment of Assignor's Interest
Recorded: 2021-07-21
Pages: 41
Assignor
MERRIMACK PHARMACEUTICALS, INC.
Executed: 2019-07-12
Assignee
14NER ONCOLOGY, INC.
888 7TH AVE. #30, NEW YORK, NEW YORK, 10106
Covered Property
(1)
Antibodies Against the Ectodomain of ERBB3 and Uses Thereof
Application:
17/376,627 →
Publication:
US 2022/0204642
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 21, 2021
From: SCHOEBERL, BIRGIT M.; NIELSEN, ULRIK B.; FELDHAUS, MICHAEL J.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 056932/0047 →
Assignment of Assignor's Interest
Jul 21, 2021
From: MURUGANANDAM, ARUMUGAM; BUCKLER, DAVID
To: DYAX CORP.
Reel/Frame 056932/0053 →
Assignment of Assignor's Interest
Jul 21, 2021
From: DYAX CORP.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 056932/0058 →
Change of Name
Jul 21, 2021
From: 14NER ONCOLOGY, INC.
To: ELEVATION ONCOLOGY, INC.
Reel/Frame 056932/0832 →